Drug-induced hearing loss as a manifestation of drug-induced ototoxicity
- 1 January 2019
- journal article
- Published by Media Sphere Publishing Group in Vestnik otorinolaringologii
- Vol. 84 (4), 72-80
- https://doi.org/10.17116/otorino20198404172
Abstract
The ability of drugs to have an ototoxic effect has been studied for a long time, however, the true prevalence of this undesirable phenomenon is unknown, which is due to the use of various audiological protocols, a wide range of reactions to drugs in different ethnic groups, and most importantly, the lack of caution with regard to otological symptoms due to their reversibility or lack of immediate threat to life. Drug-induced ototoxicity is a functional disorder of the inner ear (cochlea and/or vestibular apparatus) or eighth pair of cranial nerves. Pharmacotherapy, associated with the development of ototoxic drug reactions, may remain undervalued for a long time, often until irreversible hearing impairment is formed. The most frequently prescribed drugs that cause ototoxic phenomena include anticancer drugs, antibacterial drugs of the aminoglycoside group, loop diuretics, calcium channel blockers, non-steroidal anti-inflammatory drugs, antimalarial drugs, salicylates, etc. Monitoring the degree of hearing impairment before and during therapy is important in preventing the development of drug-induced ototoxicity and makes it possible to consider alternative treatment regimens in a timely manner. It is in this connection that the role of participation in the appointment of rational pharmacotherapy to patients with a potential risk of developing otological phenomena of a clinical pharmacologist and audiologist undoubtedly increases.Keywords
This publication has 32 references indexed in Scilit:
- Chapter 55: OtotoxicityPublished by American Society of Health-System Pharmacists ,2018
- The analysis of the association of the polymorphic variants of the TPMT, COMT, and ABCC3 genes with the development of hearing disorders induced by the cisplatin treatmentVestnik otorinolaringologii, 2018
- Platinum-induced ototoxicity: a review of prevailing ototoxicity criteriaEuropean Archives of Oto-Rhino-Laryngology, 2016
- Aminoglycoside-induced hearing deficits – a review of cochlear ototoxicitySouth African Family Practice, 2015
- Mechanisms Involved in OtotoxicitySeminars in Hearing, 2011
- Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissionsInternational Journal of Audiology, 2010
- OtotoxicityPublished by Springer Science and Business Media LLC ,2010
- Ototoxicity From Cisplatin Therapy in Childhood CancerJournal of Pediatric Hematology/Oncology, 2007
- Ototoxicity in Children Receiving Platinum Chemotherapy: Underestimating a Commonly Occurring Toxicity That May Influence Academic and Social DevelopmentJournal of Clinical Oncology, 2005
- Auditory Ototoxicity in Tuberculosis Patients Treated with DihydrostreptomycinJAMA, 1963